Duchenne muscular dystrophy is a common and devastating disease affecting males. Dr. Gyula Acsadi of the University of Connecticut outlines the clinical presentation and advances in the molecular pathogenesis of Duchenne muscular dystrophy. Early recognition of cardiac and respiratory pathophysiology and proactive management, along with corticosteroid treatment, will have a significant impact on improving the outcome of Duchenne muscular dystrophy. Various genetic therapy strategies including “exon skipping” are entering into clinical trials, thus, improving the prospect for therapy for muscular dystrophies.
To view the complete clinical summary, click here.
MedLink Neurology authors are always at work to bring you broad and up-to-date coverage of neurology topics. We are pleased to highlight clinical summaries that have been recently added or updated and to introduce the authors who write these authoritative articles. We hope you enjoy these overviews and appreciate the contributions of our more than 450 authors who keep MedLink Neurology the premier information resource for neurologists.